No abstract available
MeSH terms
-
Aged
-
Antineoplastic Agents / adverse effects*
-
Bortezomib / adverse effects*
-
Female
-
Follow-Up Studies
-
Humans
-
Male
-
Middle Aged
-
Multiple Myeloma / drug therapy*
-
Multiple Myeloma / pathology
-
Polyradiculoneuropathy / chemically induced
-
Polyradiculoneuropathy / pathology*
-
Prognosis
-
Retrospective Studies
-
Survival Rate
Substances
-
Antineoplastic Agents
-
Bortezomib